Eurosurveillance journal

@eurosurveillance.org

7086 Followers 461 Following

Weekly, peer-reviewed scientific journal on infectious disease epidemiology, prevention & control 😷🩺🧪 #OpenAccess 🔓 #PublicHealth Publisher: European Centre for Disease Prevention and Control Impact factor 2024: 7.8

Table of content issue 29 in 2026: Rapid communication Human infections with Dermatophilus sp.: travel-associated first case and a local cluster in the context of emerging European outbreaks, Basel, Switzerland, 2025 to 2026 Surveillance Epidemiology of Mycoplasma pneumoniae and co-detection with other respiratory pathogens in a respiratory sentinel surveillance system in Scotland, October 2022 to May 2025 Letters to the editor Seasonality and effects of climatic exposures on community-acquired Legionnaires’ disease incidence, Italy, 2005 to 2023 Authors’ response
Key public health message What did you want to address in this study and why? We describe national trends in reported syphilis, gonorrhoea and chlamydia in Poland between 2013 and 2024, with particular attention to the period 2020 to 2024. Poland has some of the lowest notification rates of sexually transmitted diseases (STI) in Europe, making it important to understand whether the increases observed in 2021 to 2024 reflect more infections or improved detection after disruption to healthcare services during the COVID-19 pandemic. What have we learnt from this study? Reported notifications of all three infections increased in the period 2021 to 2024, particularly among men aged 20–44 years and in urbanised regions. There were marked geographic and urban–rural differences. While syphilis notification rates approached European averages, gonorrhoea and chlamydia rates remained substantially lower, suggesting that differences in testing intensity and diagnostic access may contribute to the observed disparities. What are the implications of your findings for public health? Improving access to STI testing and ensuring that diagnosed infections are consistently reported would help public health authorities to better understand disease trends and target prevention efforts where they are needed most.
slide showing Table of content issue 28 in 2026: Rapid communication Screening and monitoring of travellers returning from countries affected by Bundibugyo virus: an overview of European approaches, July 2026 Research National automated surveillance of hospital onset bacteraemia and fungaemia using data from the national antimicrobial resistance surveillance system: a retrospective exploratory evaluation, the Netherlands, 2018 to 2023 Surveillance Trends in syphilis, gonorrhoea and chlamydia: a descriptive analysis of national surveillance data, Poland, 2013 to 2024
Table of content issue 27 in 2026: Research Autochthonous transmission patterns of dengue virus serotype 2 in Italy: evidence from outbreaks in 2024 Perspective Perspective on human diagnostic and national reference laboratory preparedness for zoonotic influenza in Europe
Slide with teh Key public health messages of the article: What did you want to address in this study and why? West Nile virus (WNV) can cause severe neurological disease in humans. In recent years, France has reported increasing numbers of WNV cases, including in regions with no previous history of virus detection. We therefore wanted to estimate, the prevalence of WNV among blood donors in mainland France, including geographical distribution and risk factors of exposure to WNV, to assess potential implications for transfusion safety and public health. What have we learnt from this study? After analysing 44,490 sera from voluntary blood donors collected in 2021–2022, we found a low overall national seroprevalence of WNV (0.97%). However, we also identified signals that WNV had been spreading silently in some unexpected areas, beyond the regions already known to be affected and several associated risk factors including region of residence and blood group. What are the implications of your findings for public health? Our findings support the need to extend WNV surveillance in humans, mosquito vectors and other accidental hosts (mainly horses and birds) beyond the known affected areas, including monitoring products of human origin (blood and organs).
GIF animation slides advertisiing teh workshop: Improving your chances to get published in scholarly journals Join the 𝙀𝙪𝙧𝙤𝙨𝙪𝙧𝙫𝙚𝙞𝙡𝙡𝙖𝙣𝙘𝙚 pre-conference workshop on 17 November 2026 in Stockholm The European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) takes place in Stockholm from 18 to 20 November 2026 What we will discuss: overview of the editorial process, from submission to publication how to choose an appropriate journal for your work and editorial considerations during the selection process preparation of the title, cover letter and abstract.
Table of content issue 26 in 2026: Research Seroprevalence of West Nile virus among blood donors in mainland France, 2021 to 2022 Artificial intelligence (AI) in action: a cross-continental survey of AI adoption among field epidemiology fellows in Canada, the United States, and Europe, 2024
Key public health message What did you want to address in this study and why? As opposed to traditional reporting, automated data extraction and processing from electronic health records (EHR) can provide more timely and easily accessible data on diseases or infections to inform prevention and control strategies. Here, we describe a European project aimed at using EHR for surveillance of bloodstream infections (BSI) and moving towards comparable data across 17 countries in the EU/EEA. What have we learnt from this study? All participating countries reported similar challenges in the implementation of automated or semi-automated EHR-based BSI surveillance systems, including data standardisation, insufficient IT capacity and data protection issues. There is a need in most countries to advance and implement standardised controlled vocabularies, common data models and validation processes. What are the implications of your findings for public health? The implementation of EHR-based surveillance systems for BSI will be essential for improving data harmonisation and quality. This project has supported the implementation and strengthening of automated EHR-based BSI surveillance across Europe. The surveillance data can ultimately lead to better infection prevention and control measures for BSI at local, national and EU levels.
Key public health message What did you want to address in this study? Infection with hepatitis C (HCV), B (HBV) and D (HDV) virus can lead to a chronic liver disease. We aimed to update estimates of hepatitis C, B and D prevalence in Germany, as previous data were largely based on blood donors or selected groups and therefore may not represent the general population. What have we learnt from this study? Hepatitis C, B and D are not widespread in Germany, but they still affect some people. Among the 10,000 people we tested, we found four people with an active HCV infection and 13 people with a past HCV infection. We also found 21 persons with an HBV infection, none of whom were confirmed infected with HDV. Importantly, some people with hepatitis did not know they were infected, showing that not all cases are currently being diagnosed. What are the implications for public health practice? Hepatitis C, B and D infections are uncommon in Germany. However, some infections remain undiagnosed, so targeted testing is important. Expanding testing, ensuring that people diagnosed with hepatitis B are also tested for hepatitis D, and improving linkage to care can help close gaps and support the goal of eliminating viral hepatitis.
Table of content issue 25 in 2026: Rapid Communication Dermatophilosis among men who have sex with men, Stockholm, Sweden, March to June, 2026 Ongoing multi-country outbreak of carbapenem-resistant Enterobacter hormaechei ST1344 carrying bla NDM-5 in the European Union/European Economic Area, March 2025 to April 2026 Detection of antibodies against avian influenza in European dairy cattle, the Netherlands, January 2026 Surveillance First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025 Research Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021
Image showing proposed transmission chains in an outbreak of measles, Alicante, Spain, 14 January−11 April 2026 (n = 34 cases) Circles represent individual cases and lines indicate probable transmission events. Connections between cases reflect epidemiological links and do not represent temporal or spatial distance.
What did you want to address in this study and why? Invasive listeriosis, caused by Listeria monocytogenes bacteria, is a rare but severe and potentially fatal illness typically occurring among individuals with weakened immune systems. We describe the evidence gathered to implicate a novel listeriosis outbreak source in an investigation that occurred in Ontario, Canada in 2024, as well as the measures implemented to prevent further illness related to this outbreak. What have we learnt from this study? The outbreak involved 20 laboratory-confirmed cases, and three deaths. All cases were infected with the same genetic strain of L. monocytogenes. Plant-based dairy alternative beverage products were implicated as the source of the outbreak, emphasising the importance of considering new sources that have not been previously implicated in L. monocytogenes outbreak investigations.
Table of content issue 24 in 2026: Rapid Communication The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026 Andes virus outbreak linked to expedition cruise ship travel, multi-country investigation and response, April to June 2026 Measles outbreak in an occupational setting: challenges to regain elimination status for Spain, 14 January to 11 April 2026 Outbreaks A new suspect: Listeria monocytogenes outbreak linked to pasteurised plant-based beverages, Canada, 2024 Surveillance Epidemiology and characteristics of cases with monkeypox virus clade I in the WHO European Region, 2024 to 2025
Table of content issue 23 in 2026: Rapid Communication Diphtheria outbreak, Northern Territory of Australia, 2025 to 2026 Research Characterising individuals with newly diagnosed HIV before versus during the era of PrEP: a descriptive time-series analysis of data from a sexual health centre in Amsterdam, the Netherlands, 2015 to 2024
Visual with teh Key public health message What did you want to address in this study and why? Measles is a highly contagious viral disease which can lead to severe consequences. When measles appears in a primary school or daycare, children may have to stay at home for several weeks, which disrupts learning and family life. We investigated whether these long quarantine periods are always necessary. The goal was to stop measles from spreading while keeping the impact on children and parents as small as possible. What have we learnt from this study? We found that in many cases, children do not need to at stay home for the full 21 days usually recommended, since shorter quarantine periods of 18 days could be enough. Schools with a vaccination coverage above 70% may also need fewer restrictions. In higher-risk situations, for example when the vaccination coverage is only 20%, vaccinating children quickly after exposure can have an additional benefit. What are the implications of your findings for public health? These findings support a more tailored approach instead of general and often strict quarantine rules for all situations. This makes the rules easier to understand, accept and follow. Informed by our simulation results, measles policy in Flanders was revised to reduce the quarantine period from 21 to 18 days in daycares, and in primary schools with a vaccination coverage below 70%.
Visual summarising the Key public health message of teh papaer: What did you want to address in this study and why? West Nile virus (WNV) is transmitted via mosquitoes to humans and other animals. Infections of West Nile virus are increasing in Europe, and the disease has a considerable impact on human health including blood and transplant safety. We aimed to estimate the average annual risk of WNV infection in humans and analyse potential differences in reporting of WNV infections across Europe. What have we learnt from this study? We identified hotspots of transmission and learnt that the average annual risk of WNV infection and reporting across the 119 European NUTS 0–3 regions included in this study is heterogeneous. Notably, we found that the locations reporting the largest number of WNV reported cases are not necessarily those experiencing the highest number of infections. What are the implications of your findings for public health? This study suggests that WNV surveillance detects different proportions of the actual (unobserved) number of infections across Europe. Seroprevalence surveys can help estimate the true number of infections, the susceptibility of the population and assess the local transmission risk.
Table of content issue 22 in 2026: Rapid Why Andes hantavirus is not the next SARS-CoV-2: contrasting viral shedding, transmissibility and genomic patterns Scenario analysis for potential community spread of Andes virus (ANDV) Research Modelling the risk of West Nile virus infection in seven European countries from published serological and case notification data, 2008 to 2022 Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium Evaluating a new partner management strategy for bacterial sexually transmitted infections after a change in 2020 in Amsterdam, the Netherlands, 2017 to 2023
Table of content issue 21 in 2026: Rapid communication Extensively drug-resistant (XDR) Neisseria gonorrhoeae cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026 Euroroundup Decreased chlamydia notifications in six European Union/European Economic Area countries and England, 2024 Surveillance Global influenza epidemiology after 2020: patterns of circulation, epidemic timing and duration, and implications for vaccination strategies Surveillance of invasive pneumococcal disease in Germany: surge in PCV13 serotypes and new challenges, 2017 to 2024
Table of content issue 20 in 2026: Rapid communication Overview of chikungunya viral transmission, French Guiana, 2026 First case of penicillin-resistant Streptococcus agalactiae (group B Streptococcus) isolated from an adult patient in Italy, February 2026 Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025 Research Targeted monitoring informed by mapping the ongoing spread of tick-borne encephalitis virus, the Netherlands Prospective use of wastewater surveillance for early detection of enterovirus D68 in community outbreaks among children, Niigata City, Japan, 2024
Table of content issue 19 in 2026: Rapid communication Rabies in a dog commercially imported into Germany from Russia, 2026 Research Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023 Current state and potential of hospitals for automated healthcare-associated infection surveillance: data from 24 European countries, 2022 to 2023
Table of content issue 18 in 2026: Rapid communication A case of carbapenamase production in Shigella flexneri isolated in Ireland, 2025 Research Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulation Genomic landscape of Candidozyma auris in Italy, 2019 to 2025: emerging diversity of clade I sub-lineages associated with inter-facility transmission and cross-border transfers SURVEILLANCE First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023
Visual summarisiing the findings of an out break of Highly pathogenic avian influenza, HPAI, A(H5N1) in poultry and domestic cats and occupational exposure among veterinary and other first responders, Germany, February 2026. Illustrated with for immages with text. 1. image: Cat and hen with text "HPAI A(H5N1) in a poultry holding. Second image: Cat and person in protective gear: infection in domestic cats/ Third image: Person in protective gear and healthcare personnel next to them: 17 exposed persons, coordinated One Health Respoinse. Fourth image with syringe, vaccine bottle and a virus image: Seasonal flu vaccination recommended.
Eurosurveillance table of content issue 5 in 2026 Rapid communication Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026 Surveillance Design and implementation of an evaluation framework for the Epidemic Intelligence from Open Sources (EIOS) system for international public health intelligence at the Robert Koch Institute, Germany, 2023 Research Detection of Aeromonas, Campylobacter and Salmonella using concurrent bacterial culture and commercial multiplex PCR, Sydney, Australia, 2023
Key public health message What did you want to address in this study and why? Women in Denmark who were vaccinated in 2008 against human papillomavirus (HPV) as girls (~14 years) have reached screening age. Compared with previous generations, these women are expected to have a considerably lower risk of cervical cancer and it is pertinent to assess the new generations’ future need for screening. We tested up to three consecutive cervical cell samples of Danish women (22–30 years) vaccinated as girls, collected between 2017 and 2024. What have we learnt from this study? Infection with HPV types covered by the vaccine (HPV16/18) has been almost eliminated. Before vaccination, the prevalence of HPV16/18 was between 15–17%, which has decreased in vaccinated women to < 1% by 2021. However, about one-third of women still had HPV infection with non-vaccine high-risk HPV types, and new infections with these types were more frequent in vaccinated than in unvaccinated women. What are the implications of your findings for public health? The HPV vaccine has been effective in reducing infections with vaccine-covered HPV types (HPV16/18), the HPV types responsible for over 70% of cervical cancer. Still, the high but steady proportion of women infected with high-risk HPV types not covered by the vaccine indicate a need for less intensive but continued screening of these generations.
Eurosurveillance table of content issue 4 in 2026 Rapid communication First detection of West Nile virus in Belgium through wild bird surveillance, Belgium, 2025 Research TORCH agents in women of fertile age: towards prevention of congenital infections, Italy, 2019 to 2020 Emergence of Neisseria meningitidis ST-3587 harbouring bla ROB-1 and exhibiting dual resistance to penicillin and ciprofloxacin, Spain, 2024
Eurosurveillance table of content issue 3 in 2026 Editorial World Leprosy Day 2026: reflections on leprosy surveillance in Europe Rapid communication First detection and autochthonous transmission of monkeypox virus clade Ib in the Netherlands, October to November, 2025 Outbreaks First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023 Surveillance Epidemiology of human salmonellosis in Czechia ─ a country with the highest European notification rate, 2012 to 2023 Perspective Integrating AMR surveillance into wastewater monitoring systems in 2025: a position on the implementation of Article 17 of the Urban Wastewater Treatment Directive (UWWTD)
Eurosurveillance table of content issue 2 in 2026 Editorial With a little help from our friends: strong collaboration and networks for public health Rapid communication Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026 Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025 High prevalence of tetracycline resistance in Neisseria gonorrhoeae across 22 European countries, 2024 Research Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS) Perspective Despite good intentions, the regulation on in vitro diagnostic medical devices (IVDR) in Europe could impact negatively on preparedness and response for the next pandemic Letter to the editor Addressing the blind spot of self-reported adherence in the era of long-acting PrEP Authors’ response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP
Eurosurveillance table of content issue 1 in 2026 Surveillance Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24 International spread or local outbreak? Epidemiologic analyses of transmission patterns of NDM-1-producing Klebsiella pneumoniae based on genomic surveillance data, Germany, January 2022 to February 2023 Research Increased incidence of human West Nile and Usutu infections in Austria, 2024: analysis of data from 2009 to 2024 Miscellaneous Eurosurveillance reviewers in 2025
IMage with animated Christmas tree ornaments, one stating Happy New Year and teh other the text "The Eurosurveillance editorial team wishes you and your loved ones a peaceful and healthy holiday season and new year. Thank you for your support in 2025 and beyond".
Eurosurveillance table of content issue 50 in 2025 Rapid communication Nosocomial transmission in a monkeypox virus clade Ib outbreak, Ireland, August to October 2025 Outbreaks Two autochthonous cases of Crimean-Congo haemorrhagic fever and the One Health response, Thessaly, Greece, 2025 Surveillance Community transmission of mpox clade Ib not driven through sexual exposures, Uvira, eastern Democratic Republic of the Congo, June to October 2024 Research Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023
Table of content Eurosurveillance issue 49 in 2025: Rapid communication Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses Rapid emergence of Trichophyton indotineae (Trichophyton mentagrophytes ITS genotype VIII) observed in the United Kingdom, up to August 2025 Lessons from an investigation of an autochthonous chikungunya outbreak in Bergerac, mainland France, June to October 2025 Outbreaks A nosocomial outbreak of Ralstonia mannitolilytica linked to cosmetic water mist sprays in the intensive care unit of a tertiary care hospital, Switzerland, 2024 Research Spatiotemporal trends and determinants of syphilis among heterosexual males and females in the Netherlands, 2011 to 2023
Table of content issue 48 in 2025 Rapid communication Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025 Surveillance Rise in the number of notifications of Shiga toxin-producing Escherichia coli (STEC) infections probably linked to an increased use of multiplex PCR assays, Germany, 2023 Trends in incidence and epidemiological characteristics of campylobacteriosis, Israel, 2013 to 2022
Picture of workshop participants sitting at their desks.
Table of content issue 47 in 2025 Rapid communication Late HIV diagnosis: trends, risk factors, and progress toward the 2025 target of <20% late diagnosis in 23 EU/EEA countries, 2022 to 2024 Increased severity of two concurrent Campylobacter jejuni clones causing large outbreaks, Denmark, July to October 2025 Research Rising scabies incidence in Spain: a retrospective observational analysis of four national data sources, 2011 to 2023 Characterisation of new HIV diagnoses achieved in emergency departments using an opt-in strategy, Catalonia, Spain, July 2021 to March 2024
Table of content issue 46 in 2025 Rapid communication Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance Global distribution of Xpert CT/NG assay Neisseria gonorrhoeae escape variants indicates sporadic emergence with limited clonality between 2016 and 2025 Outbreaks Investigation of a measles outbreak in a highly vaccinated middle school, France, 2023 Concurrent outbreaks of Escherichia coli O157:H7 and O157:H39 with high asymptomatic carriage of other Shiga toxin-producing E. coli in nursery children, south-east Scotland, United Kingdom, July to October 2022
Key public health message What did you want to address in this study and why? We aimed to investigate regional variation in hospital antibiotic use across Germany with data from 2022. Such variation is highly relevant for the development and spread of antibiotic resistance. By moving beyond hospital-level analyses and outpatient care studies, our work strengthens the national evidence base and underscores the need for coordinated strategies to ensure prudent antibiotic use across regions. What have we learnt from this study? Using a large and representative dataset, we provided more robust evidence than previous studies and generated new insights into prescribing patterns, including confirmation that both high-density and high-volume areas contribute to AMR development. Regional variations were notable, with some antibiotic groups showing up to 1.4 times higher use in certain areas, underscoring the need for targeted stewardship. What are the implications of your findings for public health? Recognising that differences in prescribing practices may reflect local guidelines, resistance rates or healthcare structures, these findings highlight the importance of incorporating regional perspectives into national antimicrobial stewardship strategies. The methodology applied here provides a model for other countries seeking to better understand and address local variation in antibiotic use as part of broader surveillance and stewardship efforts.
Image with the table of content for issue 45 in 2025: Rapid communication Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025 Preliminary report: The most considerable outbreak of Legionnaires' disease in France in the last two decades, Albertville, September 2025 Outbreaks Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024 Surveillance Antibiotic consumption patterns in acute care hospitals: an integrated analysis using regression modelling combining data from two surveillance systems, Germany, 2022 Research Higher valency vaccines’ impact on antimicrobial resistance rates in Streptococcus pneumoniae causing invasive disease: a retrospective analysis based on national reference laboratory data, Belgium, 2018 to 2023 The rise of Candidozyma auris in Czechia: three clades, prosthetic joint infection and fluconazole resistance development, 2022 to 2024
Table of content issue 44 in 2025: Rapid communication Post-authorisation experience and reported adverse events following use of a virus-like particle chikungunya vaccine, United States and Germany, up to August 2025 Outbreaks Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare porA genosubtype (19-54, 15), Spain, March to April 2024 Research Hepatitis E virus screening in solid organ transplant recipients: prevalence and implications for implementation, Spain, 2021 to 2023 Perspective Design and implementation of blood donor sample bioarchives to enhance preparedness for emerging and pandemic pathogens in England
Visual with the table of content for issue 43 in 2025: Rapid communication Death in the EU/EEA from autochthonous human rabies, Romania, July 2025: a call for action Measles vaccine virus mutation following vaccination in a healthy child resulting in a false negative vaccine specific PCR test: Ontario, Canada, 2025 Acute Brugian filariasis in a German tourist after short-term travel to Sri Lanka, 2025 Research A framework for facilitating sustainable One Health collaboration across sectors at the national level in the European Union/European Economic Area Outbreaks A 46-week outbreak of ertapenem-resistant, non-carbapenemase encoding Klebsiella pneumoniae ST45 in a paediatric cardiac unit involving shared equipment, United Kingdom, April 2022 to February 2023
Visual advertising the ESCAIDE seminar on 20 November 2025 from 14:00-15:30 CET Moderator: Susana Monge, Instituto de Salud Carlos III Speakers: Mateusz Hasso-Agopsowicz World Health Organization: ‘The role of vaccines in reducing antimicrobial resistance and use' Gerald McInerney, Karolinska Institutet: 'How basic research informed the development of the chikungunya virus vaccine' Fernanda Boulos Instituto Butantan: 'Dengue: strategies for prevention and control'
Table of content issue 41 in 2025 Rapid communication Third Streptococcus pneumoniae disease outbreak involving serotype 4–ST801 in a shipyard, Finland, May to June 2025 Outbreaks Case series of Oropouche fever among travellers returning from Cuba to Spain, 2024 A community Legionnaires’ disease outbreak linked to a collective biomass condensing boiler, France, 2019 Euroroundup Insights into recurring multi-country outbreaks of Salmonella Strathcona associated with tomatoes, Europe, 2011 to 2024 Perspective When to take action in food-borne disease outbreaks?
TABLE OF CONTENT ISSUE 40 IN 2025: Rapid communication Autochthonous transmission of extensively drug-resistant Neisseria gonorrhoeae in Germany, 2025 Surveillance Epidemiology and risk factors of Escherichia coli bloodstream infections associated with extended-spectrum beta-lactamase production: a national surveillance and data linkage study, Finland, 2018 to 2023 Primary care sentinel surveillance of influenza-like illness and laboratory detections of respiratory viral infections in Denmark, week 40 2021 to week 39 2023 Letter to the editor and author's response Peanut butter confirmed as the source in a case of infant botulism, United Kingdom, 2024
Visual advertising the Eurosurveillance seminar at ESCAIDE 2025 on 20 November 2025, 14:00- 15:30 CET Title of the seminar: Vaccines and tomorrow's opportunities for public health Speakers: Mateusz Hasso-Agopsowicz World Health Organization: ‘The role of vaccines in reducing antimicrobial resistance and use' Gerald McInerney Karolinska Institutet: 'How basic research informed the development of the chikungunya virus vaccine' Fernanda Boulos Instituto Butantan: 'Dengue: strategies for prevention and control'